Differences between the mutational consequences of replication of cis- and trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide-deoxyguanosine adducts in M13mp7L2 constructs

Chemical Research in Toxicology

Volumn 14, Issue 6, 2001, Pages 720-726

  Ponten I ^a,c   Kroth, H ^b   Sayer, J M ^b   Dipple, A ^a,c   Jerina, D M ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; DEOXYGUANOSINE; EPOXIDE; GUANINE;

ARTICLE; ESCHERICHIA COLI; GENE DELETION; GENE INSERTION; ISOMER; MUTATION; NUCLEIC ACID BASE SUBSTITUTION; STEREOCHEMISTRY;

EID: 0034977788     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0002684     Document Type: Article

References (46)

1. Site-specific mutagenesis: Retrospective and prospective
2. The role of adduct site-specific mutagenesis in understanding how carcinogen-DNA adducts cause mutations: Perspective, prospects and problems
3. Metabolic activation of benzo[a]pyrene proceeds by a diolepoxide
4. Metabolism of benzo[a]pyrene: Conversion of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides
5. Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: Exceptional activity of (+)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene
6. Identification of mutagenic metabolites of benzo[a]pyrene in mammalian cells
7. Mutagenicity and cytotoxicity of benzo[a]pyrene benzo-ring epoxides
8. Mutagenicity of isomeric diol-epoxides of benzo[a]pyrene and benz[a]anthracene in S. typhimurium TA98 and TA100 and in V79 Chinese hamster cells
9. Differences in mutagenicity of the optical enantiomers of the diastereomeric benzo[a]-pyrene 7,8-diol-9,10-epoxides
10. A quantitative comparison of the mutagenicity of carcinogenic polycyclic hydrocarbon derivatives in cultured mammalian cells
11. Mutation in mammalian cells by stereoisomers of anti-benzo[a]pyrene-diolepoxide in relation to the extent and nature of the DNA reaction products
12. Benzo[a]pyrene diol-epoxides: Different mutagenic efficiency in human and bacterial cells
13. Kinds of mutation formed when a shuttle vector containing adducts of (±)-7β,8α-dihyroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo[a]-pyrene replicates in human cells
14. Effect of excision repair by diploid human fibroblasts on the kinds and locations of mutations induced by (±)-7β,8α-dihydroxy-9α,10αepoxy-7,8,9,10- tetrahydrobenzo[a]pyrene in the coding region of the HPRT gene
15. Strand specificity for mutations induced by (+)-anti BPDE in the hprt gene in human T-lymphocytes
16. AP sites are not significantly involved in mutagenesis by the (+)-anti diol epoxide of benzo[a]pyrene: The complexity of its mutagenic specificity is likely to arise from adduct conformational polymorphism
17. Mutagenic selectivity at the HPRT locus in V-79 cells: Comparison of mutations caused by bay-region benzo[a]pyrene 7,8-diol-9,10-epoxide enantiomers with high and low carcinogenic activity
18. 2-Gua adduct of the (+)-anti-benzo[a]pyrene diol epoxide is capable of inducing G - A and G - C, in addition to G - T, mutations
19. 6 at the second position of N-ras codon 61
20. Fidelity of translesional synthesis past benzo[a]pyrene diol epoxide-2′-deoxyguanosine DNA adducts: Marked effects of host cell, sequence context, and chirality
21. Sequence specific mutagenesis of the major (+)-anti-benzo[a]pyrene diol epoxide-DNA adduct at a mutational hot spot in vitro and in Escherichia coli cells
22. 2-deoxyguanosine adducts of 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene: Configuration of the adduct bond is more important than those of the hydroxyl groups
23. 2-2′-deoxyguanosine adducts in Escherichia coli and simian kidney cells
24. Sequence context profoundly influences the mutagenic potency of trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide-purine nucleoside adducts in site-specific mutation studies
25. Mutagenic replication in a human cell extract of DNAs containing site-specific and stereospecific benzo[a]pyrene-7,8-diol-9,10-epoxide DNA adducts placed on the leading and lagging strands
26. Mutational consequences of replication of M13mp7L2 constructs containing cis-opened benzo[a]pyrene 7,8-diol 9,10-epoxide deoxyadenosine adducts
27. 6-Allyl protected deoxyguanosine adducts of polycyclic aromatic hydrocarbons as building blocks for the synthesis of oligonucleotides
28. Sequence context effects on mutational properties of cis-opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts in site-specific mutation studies
29. Factors determining mutagenic potential for individual cis and trans opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts
30. Mutation frequency and spectrum resulting from a single abasic site in a single-stranded vector
31. U - U and T - T cyclobutane dimers have different mutational properties
32. Influence of adduct position and sequence length on the ligation of oligonucleotides containing benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts into M13mp7L2
33. Mutational specificity of the (+)-anti-diol epoxide of benzo[a]pyrene in a supF gene of an Escherichia coli plasmid: DNA sequence context influences hotspots, mutagenic specificity and the extent of SOS enhancement of mutagenesis
34. The processing of a benzo[a]pyrene adduct into a frameshift or a base substitution mutation requires a different set of genes in Escherichia coli
35. DNA replication fidelity
36. Solution conformation of the major adduct between the carcinogen (+)-anti-benzo[a]pyrene diol epoxide and DNA
37. Influence of benzo[a]pyrene diol epoxide chirality on solution conformations of DNA covalent adducts: The (-)-trans-anti-[BP]G·C adduct structure and comparison with the (+)-trans-anti-[BP]G·C enantiomer
38. Solution conformation of the (+)-cis-anti-[BP]dG adduct in a DNA duplex: Intercalation of the covalently attached benzo[a]pyrenyl ring into the helix and displacement of the modified deoxyguanosine
39. Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: Intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove
40. Structural alignments of (+)-and (-)-trans-anti-benzo [a]pyrene- dG adducts positioned at a DNA template-primer junction
41. Structural alignment of the (+)-trans-anti-benzo[a]pyrene-dG adduct positioned opposite dC at a DNA template-primer junction
42. Solution structure of the (+)-cis-anti-benzo[a]pyrene-dA ([BP]dA) adduct opposite dT in a DNA duplex
43. 6-[10-(7,8,9,10-tetrahydrobenzo[a]pyrenyl)]- 2′-deoxyadenosyl adduct in the N-ras codon 61 sequence
44. Adduction of the human N-ras codon 61 sequence with (-)-(7S,8R,9R,10S)-7,8-dihydroxy-9,10-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene: Structural refinement of the intercalated SRSR(61,2) (-)-(7S,8R,9S,10R)-N6-[10-(7,8,9,10-tetrahydrobenzo[a]pyrenyl)]-2′- deoxyadenosyl adduct from 1H NMR
45. NMR evidence for syn-anti interconversion of a trans opened (10R)-dA adduct of Benzo[a]pyrene (7S,8R)-diol (9R,10S)-epoxide in a DNA duplex